Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments

Yutaka Horiguchi, Eiji Kikuchi, Choichiro Ozu, Toru Nishiyama, Masafumi Oyama, Minoru Horinaga, Kunihiko Yoshioka, Masaaki Tachibana

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Various animal models of bladder tumor have been developed for the preclinical evaluation of therapeutic modalities for the treatment of bladder cancers. The ideal model for the investigation of therapeutic effects of proposed novel intravesical treatments requires the mass of the implanted tumor to be confined to the urothelium of the bladder at least for the initial phase. However, previously reported bladder tumor models are not suitable for the evaluation of intravesical therapies for the treatment of superficial bladder cancer, since the muscle invasive tumors have developed from the beginnings of the experiments. These models are too aggressive to study local treatment effects. In the current study, we demonstrated that careful instillation of MBT-2 mouse bladder cancer cells into the bladder of a syngenic C3H/HeJ mouse could establish a superficial bladder tumor with an incidence of 100%. The procedure and technique for handling animals are simple for standard animal investigators. Maintenance of the in vitro conditions of MBT-2 cells without contamination of Mycoplasma and careful selection of the substrain of C3H mouse seem to be essential for stable tumor establishment. This bladder tumor model appeared to be easy to reproduce among several investigators in different institutions. The orthotopic bladder tumor model, which was confined to urothelium, lets us evaluate various intravesical treatment strategies.

Original languageEnglish
Pages (from-to)57-63
Number of pages7
JournalHuman Cell
Volume21
Issue number3
DOIs
Publication statusPublished - 2008 Aug

Fingerprint

Urinary Bladder Neoplasms
Urothelium
Inbred C3H Mouse
Urinary Bladder
Muscle Neoplasms
Research Personnel
Neoplasms
Mycoplasma
Therapeutic Uses
Animal Models
Maintenance
Incidence
Therapeutics

Keywords

  • Animal model
  • Bladder cancer
  • Intravesical therapy
  • MBT-2
  • Orthotopic

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

Horiguchi, Y., Kikuchi, E., Ozu, C., Nishiyama, T., Oyama, M., Horinaga, M., ... Tachibana, M. (2008). Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments. Human Cell, 21(3), 57-63. https://doi.org/10.1111/j.1749-0774.2008.00055.x

Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments. / Horiguchi, Yutaka; Kikuchi, Eiji; Ozu, Choichiro; Nishiyama, Toru; Oyama, Masafumi; Horinaga, Minoru; Yoshioka, Kunihiko; Tachibana, Masaaki.

In: Human Cell, Vol. 21, No. 3, 08.2008, p. 57-63.

Research output: Contribution to journalArticle

Horiguchi, Y, Kikuchi, E, Ozu, C, Nishiyama, T, Oyama, M, Horinaga, M, Yoshioka, K & Tachibana, M 2008, 'Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments', Human Cell, vol. 21, no. 3, pp. 57-63. https://doi.org/10.1111/j.1749-0774.2008.00055.x
Horiguchi, Yutaka ; Kikuchi, Eiji ; Ozu, Choichiro ; Nishiyama, Toru ; Oyama, Masafumi ; Horinaga, Minoru ; Yoshioka, Kunihiko ; Tachibana, Masaaki. / Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments. In: Human Cell. 2008 ; Vol. 21, No. 3. pp. 57-63.
@article{c5e5e935071a4b1eac2dcd5c3a579bf4,
title = "Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments",
abstract = "Various animal models of bladder tumor have been developed for the preclinical evaluation of therapeutic modalities for the treatment of bladder cancers. The ideal model for the investigation of therapeutic effects of proposed novel intravesical treatments requires the mass of the implanted tumor to be confined to the urothelium of the bladder at least for the initial phase. However, previously reported bladder tumor models are not suitable for the evaluation of intravesical therapies for the treatment of superficial bladder cancer, since the muscle invasive tumors have developed from the beginnings of the experiments. These models are too aggressive to study local treatment effects. In the current study, we demonstrated that careful instillation of MBT-2 mouse bladder cancer cells into the bladder of a syngenic C3H/HeJ mouse could establish a superficial bladder tumor with an incidence of 100{\%}. The procedure and technique for handling animals are simple for standard animal investigators. Maintenance of the in vitro conditions of MBT-2 cells without contamination of Mycoplasma and careful selection of the substrain of C3H mouse seem to be essential for stable tumor establishment. This bladder tumor model appeared to be easy to reproduce among several investigators in different institutions. The orthotopic bladder tumor model, which was confined to urothelium, lets us evaluate various intravesical treatment strategies.",
keywords = "Animal model, Bladder cancer, Intravesical therapy, MBT-2, Orthotopic",
author = "Yutaka Horiguchi and Eiji Kikuchi and Choichiro Ozu and Toru Nishiyama and Masafumi Oyama and Minoru Horinaga and Kunihiko Yoshioka and Masaaki Tachibana",
year = "2008",
month = "8",
doi = "10.1111/j.1749-0774.2008.00055.x",
language = "English",
volume = "21",
pages = "57--63",
journal = "Human Cell",
issn = "0914-7470",
publisher = "Springer Heidelberg",
number = "3",

}

TY - JOUR

T1 - Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments

AU - Horiguchi, Yutaka

AU - Kikuchi, Eiji

AU - Ozu, Choichiro

AU - Nishiyama, Toru

AU - Oyama, Masafumi

AU - Horinaga, Minoru

AU - Yoshioka, Kunihiko

AU - Tachibana, Masaaki

PY - 2008/8

Y1 - 2008/8

N2 - Various animal models of bladder tumor have been developed for the preclinical evaluation of therapeutic modalities for the treatment of bladder cancers. The ideal model for the investigation of therapeutic effects of proposed novel intravesical treatments requires the mass of the implanted tumor to be confined to the urothelium of the bladder at least for the initial phase. However, previously reported bladder tumor models are not suitable for the evaluation of intravesical therapies for the treatment of superficial bladder cancer, since the muscle invasive tumors have developed from the beginnings of the experiments. These models are too aggressive to study local treatment effects. In the current study, we demonstrated that careful instillation of MBT-2 mouse bladder cancer cells into the bladder of a syngenic C3H/HeJ mouse could establish a superficial bladder tumor with an incidence of 100%. The procedure and technique for handling animals are simple for standard animal investigators. Maintenance of the in vitro conditions of MBT-2 cells without contamination of Mycoplasma and careful selection of the substrain of C3H mouse seem to be essential for stable tumor establishment. This bladder tumor model appeared to be easy to reproduce among several investigators in different institutions. The orthotopic bladder tumor model, which was confined to urothelium, lets us evaluate various intravesical treatment strategies.

AB - Various animal models of bladder tumor have been developed for the preclinical evaluation of therapeutic modalities for the treatment of bladder cancers. The ideal model for the investigation of therapeutic effects of proposed novel intravesical treatments requires the mass of the implanted tumor to be confined to the urothelium of the bladder at least for the initial phase. However, previously reported bladder tumor models are not suitable for the evaluation of intravesical therapies for the treatment of superficial bladder cancer, since the muscle invasive tumors have developed from the beginnings of the experiments. These models are too aggressive to study local treatment effects. In the current study, we demonstrated that careful instillation of MBT-2 mouse bladder cancer cells into the bladder of a syngenic C3H/HeJ mouse could establish a superficial bladder tumor with an incidence of 100%. The procedure and technique for handling animals are simple for standard animal investigators. Maintenance of the in vitro conditions of MBT-2 cells without contamination of Mycoplasma and careful selection of the substrain of C3H mouse seem to be essential for stable tumor establishment. This bladder tumor model appeared to be easy to reproduce among several investigators in different institutions. The orthotopic bladder tumor model, which was confined to urothelium, lets us evaluate various intravesical treatment strategies.

KW - Animal model

KW - Bladder cancer

KW - Intravesical therapy

KW - MBT-2

KW - Orthotopic

UR - http://www.scopus.com/inward/record.url?scp=48449090687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449090687&partnerID=8YFLogxK

U2 - 10.1111/j.1749-0774.2008.00055.x

DO - 10.1111/j.1749-0774.2008.00055.x

M3 - Article

VL - 21

SP - 57

EP - 63

JO - Human Cell

JF - Human Cell

SN - 0914-7470

IS - 3

ER -